Axolotl

Axolotl Biosciences is a biotechnology company specializing in the development of advanced 3D bioprinting solutions and specialized bioinks for the creation of functional human tissue models. As a spin-off from the University of Victoria, the company focuses on bioactive materials, such as AxoGel and tissue-specific bioinks, that support the maintenance and differentiation of induced pluripotent stem cells (iPSCs). Their platform enables the production of physiologically relevant models for neural and cardiac tissues, facilitating drug discovery and academic research in areas such as Alzheimer's and Parkinson's disease. Axolotl Biosciences aims to bridge the gap between traditional cell culture and clinical applications by providing high-fidelity, reproducible tissue engineering tools for the regenerative medicine industry.